Weinkle Susan H, Werschler W Philip, Teller Craig F, Sykes Jonathan M, Shamban Ava, Rivkin Alexander, Narurkar Vic A, Kaminer Michael S, Dayan Steven, Cohen Joel L, Gallagher Conor J
Affiliate Clinical Professor of Dermatology, University of South Florida, Tampa, FL.
Assistant Clinical Professor of Medicine/Dermatology, University of Washington, School of Medicine, Seattle, WA.
Aesthet Surg J. 2018 Apr 6;38(5):540-556. doi: 10.1093/asj/sjx179.
Individuals seeking aesthetic treatment have concerns regarding multiple facial areas.
Assess the aesthetic impact and satisfaction achieved with a multimodal approach to aesthetic treatment using a combination of minimally invasive treatments.
Prospective, multicenter, rater-blinded, 4-month HARMONY study evaluated patient satisfaction and aesthetic impact of a combination of fillers (VYC-20L, HYC-24L, and HYC-24L+), onabotulinumtoxinA, and bimatoprost. Males and females aged 35 to 65 years received on-label, staged treatment with fillers, as needed per investigator assessment, on day 1, with touch ups allowed on day 14. Bimatoprost was self-administered once daily for 17 weeks. OnabotulinumtoxinA was injected into glabellar lines, crow's feet lines, or both at month 3. Primary effectiveness measure was mean change from baseline on the FACE-Q 10-item Satisfaction with Facial Appearance Overall Scale.
Of 100 patients treated, 93 underwent at least the 4-month posttreatment assessment and were assessed for efficacy. The FACE-Q Satisfaction with Facial Appearance Overall Scale total score increased from baseline (41.2) to month 4 (72.9; P < 0.00001; effect size, 2.7). Improvement following multimodal treatment was observed on FACE-Q individual items. Self-perceived age decreased from 0.2 years older than actual age at baseline to 4.6 years younger at month 4. Nearly all patients (99%) rated themselves as improved or much improved on the Global Aesthetic Improvement Scale. Investigator assessments also demonstrated improvement. Mild to moderate adverse events occurred in 42 patients.
Minimally invasive, multimodal treatment resulted in improvements in FACE-Q scores and perceived age, indicating a high degree of patient satisfaction and a younger facial appearance.
寻求美容治疗的个体对多个面部区域存在担忧。
评估采用多种微创治疗相结合的多模式美容治疗方法所取得的美学效果和满意度。
前瞻性、多中心、评估者盲法的4个月和谐研究评估了填充剂(VYC - 20L、HYC - 24L和HYC - 24L +)、肉毒毒素A和比马前列素联合使用时患者的满意度和美学效果。年龄在35至65岁的男性和女性在第1天接受按研究者评估按需进行的填充剂标记内分阶段治疗,第14天允许进行补打。比马前列素每日自行给药一次,持续17周。在第3个月时将肉毒毒素A注射到眉间纹、鱼尾纹或两者中。主要疗效指标是在面部外观总体满意度面部Q 10项量表上相对于基线的平均变化。
在接受治疗的100名患者中,93名接受了至少4个月的治疗后评估并进行了疗效评估。面部外观总体满意度面部Q量表总分从基线时的41.2分提高到第4个月时的72.9分(P < 0.00001;效应量为2.7)。在面部Q的各个项目上均观察到多模式治疗后的改善。自我感知年龄从基线时比实际年龄大0.2岁降至第4个月时比实际年龄小4.6岁。几乎所有患者(99%)在全球美学改善量表上给自己的评价为改善或显著改善。研究者的评估也显示有改善。42名患者发生了轻度至中度不良事件。
微创多模式治疗使面部Q评分和感知年龄得到改善,表明患者满意度高且面部外观更显年轻。